A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Clinical trial NCT03538028 · COMPLETED

Trial details

NCT number: NCT03538028
Sponsor: Incyte Biosciences International Sàrl
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer Microsatellite Instability (MSI)-High Endometrial Cancer Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Esophageal Cancer Hepatocellular Carcinoma Melanoma (Uveal Melanoma Excluded)Merkel Cell Carcinoma Mesothelioma MSI-high Colorectal Cancer Non-small Cell Lung Cancer (NSCLC)Ovarian Cancer Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Start date: 2018-06-18
Primary completion: 2020-10-07
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.